International Network of VENous Thromboembolism Clinical Research Networks


Site News
« Back to listings

INVENT Endorsed High Low study (LMWH to Prevent Recurrent Venous Thromboembolism in Pregnancy: A Randomized Controlled Trial of Two Doses) has recruited 767 patients of 1000 patients - as of February 25, 2019. The study began in 2013 and has sites in seven counties participating in the recruiting efforts.

For more information about the study, please visit the study website or the clinical trials page.


There are currently no comments.

Log in to post a comment.


* indicates required

Contact Permissions

Please select the ways you would like to hear from INVENT Network:

Contact Permissions

By clicking below to subscribe, you agree to the terms of our privacy policy.